105 related articles for article (PubMed ID: 2865917)
1. Assessing the efficacy and safety of q. d. theophylline therapy: a multicenter study.
Dockhorn RJ; Green AW; Green E
Ann Allergy; 1985 Nov; 55(5):658-64. PubMed ID: 2865917
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of once daily extended-release theophylline in decreasing the use of inhaled beta 2-agonists in stable, mild-to-moderate asthma patients.
Edwards TB; Dockhorn RJ; Wagner DE; Fiddes RA; Grossman J; Menendez R; Southern DL; Cefali EA; Hassanein RS
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):409-16. PubMed ID: 7583862
[TBL] [Abstract][Full Text] [Related]
3. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
Goldstein MF; Chervinsky P
Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
[TBL] [Abstract][Full Text] [Related]
6. Sustained-release theophylline therapy for chronic childhood asthma.
Bell T; Bigley J
Pediatrics; 1978 Sep; 62(3):352-8. PubMed ID: 704210
[TBL] [Abstract][Full Text] [Related]
7. Lack of significant arrhythmogenicity from chronic theophylline and beta-2-adrenergic combination therapy in asthmatic subjects.
Kelly HW; Menendez R; Voyles W
Ann Allergy; 1985 May; 54(5):405-10. PubMed ID: 2859818
[TBL] [Abstract][Full Text] [Related]
8. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
[TBL] [Abstract][Full Text] [Related]
9. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
10. Optimal time for obtaining peak and trough theophylline levels in 12-hour and 24-hour products in children.
Tinkelman DG; Lutz CN; Miller E; Cole WQ
Ann Allergy; 1987 Mar; 58(3):190-2. PubMed ID: 3826771
[TBL] [Abstract][Full Text] [Related]
11. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
Katz RM; Rachelefsky GS; Siegel SC; Mickey R
Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of sustained-released theophylline on peak expiratory flow rate in asthmatic patients].
Yoshimine F; Sasagawa M; Kon Y; Yamaguchi S; Suzuki E; Gejyo F
Arerugi; 2000 Jul; 49(7):593-9. PubMed ID: 10944826
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
[TBL] [Abstract][Full Text] [Related]
14. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.
Arkinstall WW; Atkins ME; Harrison D; Stewart JH
Am Rev Respir Dis; 1987 Feb; 135(2):316-21. PubMed ID: 3813191
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
Iwasaki E; Baba M
Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
[TBL] [Abstract][Full Text] [Related]
16. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
Rogers RJ; Wiener MB; Hill MR; Szefler SJ
Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
[TBL] [Abstract][Full Text] [Related]
17. [Long-term stability of morning serum theophylline level in asthma patients under minimally 1-year therapy with Euphylong].
Siebert B; Kunkel G; Staudinger HW; Böhm A; Steinijans VW
Pneumologie; 1991 Nov; 45 Suppl 4():848-52. PubMed ID: 1812478
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma].
Ukena D; Harnest U; Sakalauskas R; Magyar P; Vetter N; Steffen H; Leichtl S; Rathgeb F; Keller A; Steinijans VW
Pneumologie; 1998 Jul; 52(7):377-84. PubMed ID: 9738388
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
[TBL] [Abstract][Full Text] [Related]
20. Combined theophylline/beta-agonists maintenance therapy in chronic asthma.
Eriksson NE; Haglind K; Ewald U
Eur J Respir Dis; 1983 Apr; 64(3):172-7. PubMed ID: 6132832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
